155 related articles for article (PubMed ID: 11810131)
1. Long-term follow-up of transplanted kidneys according to plasma volume expander of kidney donors.
Cittanova ML; Mavré J; Riou B; Coriat P
Intensive Care Med; 2001 Nov; 27(11):1830. PubMed ID: 11810131
[No Abstract] [Full Text] [Related]
2. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients.
Cittanova ML; Leblanc I; Legendre C; Mouquet C; Riou B; Coriat P
Lancet; 1996 Dec; 348(9042):1620-2. PubMed ID: 8961992
[TBL] [Abstract][Full Text] [Related]
3. Deleterious renal effects of hydroxyethyl starch 130/0.4 and 200/0.5 solutions.
Davidson IJ
Eur J Anaesthesiol; 2007 Oct; 24(10):892-3. PubMed ID: 17977101
[No Abstract] [Full Text] [Related]
4. Risks of hydroxyethyl starch 130/0.4 in cardiac surgery.
Haynes GR
J Pharm Pract; 2014 Feb; 27(1):17-8. PubMed ID: 24436438
[No Abstract] [Full Text] [Related]
5. Hydroxyethylstarch and renal function in kidney transplant recipients.
Holzheimer R
Lancet; 1997 Mar; 349(9055):883-4; author reply 884. PubMed ID: 9121292
[No Abstract] [Full Text] [Related]
6. Gelatin solutions for critically unwell septic adults.
Patel A; Brett SJ
Br J Hosp Med (Lond); 2013 Nov; 74(11):657. PubMed ID: 24220537
[No Abstract] [Full Text] [Related]
7. Hydroxyethylstarch and renal function in kidney transplant recipients.
Coronel B; Mercatello A; Martin X; Lefrancois N
Lancet; 1997 Mar; 349(9055):884; author reply 884. PubMed ID: 9121293
[No Abstract] [Full Text] [Related]
8. Hydroxyethyl starches: a tale of two contexts: the problem of knowledge.
Weiskopf RB
Anesth Analg; 2014 Sep; 119(3):509-513. PubMed ID: 25136996
[No Abstract] [Full Text] [Related]
9. Impact of fluid infusion rate on restoring plasma volume in sepsis.
Ishihara H
Crit Care Med; 2013 Mar; 41(3):931-2. PubMed ID: 23425836
[No Abstract] [Full Text] [Related]
10. [Not Available].
Hahn R
Lakartidningen; 2018 May; 115():. PubMed ID: 29738050
[No Abstract] [Full Text] [Related]
11. Renal impact of fluid management with colloids.
Boldt J
Eur J Anaesthesiol; 2007 Oct; 24(10):891-2. PubMed ID: 17977100
[No Abstract] [Full Text] [Related]
12. Comparison of 6% hydroxyethyl starch and 5% albumin for volume replacement therapy in patients undergoing cystectomy (CHART): study protocol for a randomized controlled trial.
Kammerer T; Klug F; Schwarz M; Hilferink S; Zwissler B; von Dossow V; Karl A; Müller HH; Rehm M
Trials; 2015 Aug; 16():384. PubMed ID: 26314293
[TBL] [Abstract][Full Text] [Related]
13. NHS should ban use of starch based intravenous fluids, say researchers.
Wise J
BMJ; 2013 Feb; 346():f1323. PubMed ID: 23447423
[No Abstract] [Full Text] [Related]
14. Stable creatinine clearance using large-dose HES versus reduced GFR.
Neff TA; Stocker R
Kidney Int; 2004 Mar; 65(3):1111; author reply 1111-2. PubMed ID: 14871435
[No Abstract] [Full Text] [Related]
15. Trauma experts urge cautious use of i.v. fluids.
Traynor K
Am J Health Syst Pharm; 2012 Nov; 69(21):1846, 1848. PubMed ID: 23111663
[No Abstract] [Full Text] [Related]
16. Is Brain-Dead Donor Fluid Therapy With Colloids Associated With Better Kidney Grafts?
Limnell N; Schramko AA
Exp Clin Transplant; 2018 Feb; 16(1):55-60. PubMed ID: 28621636
[TBL] [Abstract][Full Text] [Related]
17. Benefits of hydroxyethyl starch: lost in translation?
Gosling P
Crit Care Med; 2008 Oct; 36(10):2949-50. PubMed ID: 18812807
[No Abstract] [Full Text] [Related]
18. Data too important to share: do those who control the data control the message?
Doshi P
BMJ; 2016 Mar; 352():i1027. PubMed ID: 26936297
[No Abstract] [Full Text] [Related]
19. The risk of infusing gelatin? Die-hard misconceptions and forgotten (or ignored) truths.
Pisano A; Landoni G; Bellomo R
Minerva Anestesiol; 2016 Oct; 82(10):1107-1114. PubMed ID: 27045639
[TBL] [Abstract][Full Text] [Related]
20. Nephrotoxicity of hydroxyethyl starch solution.
Brunkhorst FM; Oppert M
Br J Anaesth; 2008 Jun; 100(6):856; author reply 856-7. PubMed ID: 18483113
[No Abstract] [Full Text] [Related]
[Next] [New Search]
